Medicenna Therapeutics Corp.
MDNA.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.49M | 7.74M | 11.31M | 15.00M | 17.28M |
| Total Receivables | 966.70K | 1.07M | 906.70K | 859.30K | 1.88M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 517.10K | 609.00K | 618.10K | 694.40K | 444.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.97M | 9.42M | 12.83M | 16.55M | 19.60M |
|
|
|||||
| Total Current Assets | 5.97M | 9.42M | 12.83M | 16.55M | 19.60M |
| Net Property, Plant & Equipment | 64.60K | 75.10K | 86.20K | 104.10K | 110.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 33.80K | 35.00K | 35.20K | 36.70K | 36.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.07M | 9.53M | 12.95M | 16.70M | 19.75M |
|
|
|||||
| Total Accounts Payable | 3.48M | 3.10M | 2.62M | 2.34M | 1.88M |
| Total Accrued Expenses | 396.40K | 369.00K | 539.20K | 973.00K | 1.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 46.70K | 47.40K | 44.50K | 42.50K | 34.10K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.93M | 3.52M | 3.20M | 3.35M | 3.09M |
|
|
|||||
| Total Current Liabilities | 3.93M | 3.52M | 3.20M | 3.35M | 3.09M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 38.80K | 51.10K | 62.50K | 76.30K | 82.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 325.30K | 1.43M | 2.34M | 2.53M | 3.29M |
| Total Liabilities | 4.29M | 5.00M | 5.60M | 5.96M | 6.46M |
|
|
|||||
| Common Stock & APIC | 99.82M | 101.07M | 99.26M | 101.03M | 88.71M |
| Retained Earnings | -98.15M | -96.58M | -91.94M | -90.32M | -82.27M |
| Treasury Stock & Other | 113.50K | 39.40K | 36.60K | 25.70K | 6.84M |
| Total Common Equity | 1.78M | 4.53M | 7.35M | 10.74M | 13.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.78M | 4.53M | 7.35M | 10.74M | 13.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.78M | 4.53M | 7.35M | 10.74M | 13.28M |
|
|
|||||